OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY

Kathrine Grøn; Bente Glintborg; Frank Mehnert; Mikkel Østergaard; Lene Dreyer; Mette Nørgaard; Niels Steen Krogh; Merete L. Hetland

doi:10.1136/annrheumdis-2019-eular.1478

OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY

Kathrine Grøn, Bente Glintborg, Frank Mehnert, Mikkel Østergaard, Lene Dreyer, Mette Nørgaard, Niels Steen Krogh, Merete L. Hetland

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	THU0667
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	78
Udgave nummer	Suppl 2
Sider (fra-til)	630
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2019-eular.1478
Status	Udgivet - 2019

Adgang til dokumentet

10.1136/annrheumdis-2019-eular.1478

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Grøn, K., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., & Hetland, M. L. (2019). OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY. Annals of the Rheumatic Diseases, 78(Suppl 2), 630. Artikel THU0667. https://doi.org/10.1136/annrheumdis-2019-eular.1478

OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY. / Grøn, Kathrine; Glintborg, Bente; Mehnert, Frank et al.
I: Annals of the Rheumatic Diseases, Bind 78, Nr. Suppl 2, THU0667, 2019, s. 630.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Grøn, K, Glintborg, B, Mehnert, F, Østergaard, M, Dreyer, L, Nørgaard, M, Krogh, NS & Hetland, ML 2019, 'OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY', Annals of the Rheumatic Diseases, bind 78, nr. Suppl 2, THU0667, s. 630. https://doi.org/10.1136/annrheumdis-2019-eular.1478

@article{de542ef166784a2d85b1d0f7ace959e2,

title = "OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY",

author = "Kathrine Gr{\o}n and Bente Glintborg and Frank Mehnert and Mikkel {\O}stergaard and Lene Dreyer and Mette N{\o}rgaard and Krogh, {Niels Steen} and Hetland, {Merete L.}",

year = "2019",

doi = "10.1136/annrheumdis-2019-eular.1478",

language = "English",

volume = "78",

pages = "630",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB

T2 - AN OBSERVATIONAL COHORT STUDY

AU - Grøn, Kathrine

AU - Glintborg, Bente

AU - Mehnert, Frank

AU - Østergaard, Mikkel

AU - Dreyer, Lene

AU - Nørgaard, Mette

AU - Krogh, Niels Steen

AU - Hetland, Merete L.

PY - 2019

Y1 - 2019

U2 - 10.1136/annrheumdis-2019-eular.1478

DO - 10.1136/annrheumdis-2019-eular.1478

M3 - Conference abstract in journal

SN - 0003-4967

VL - 78

SP - 630

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - THU0667

ER -